| Bioactivity | Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes[1]. |
| Name | Ofatumumab |
| CAS | 679818-59-8 |
| Appearance | Liquid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sanford M, McCormack PL. Ofatumumab. Drugs. 2010;70(8):1013-1019. |